http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019362856-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6784372aa482f6c62b3c468693641159
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N7-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N7-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16C20-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16C20-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
filingDate 2019-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53b11da529d889c33f3f07dce1f70b7c
publicationDate 2019-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2019362856-A1
titleOfInvention Population pharmacokinetics tools and uses thereof
abstract The present invention is directed to computer based pharmacokinetics systems, such as, web-based pharmacokinetics systems, and their use to predict a dose and a dosing interval for a patient in need of a clotting factor therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022155292-A1
priorityDate 2013-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10325687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9233145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10656167-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9250

Total number of triples: 38.